908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Revenue of 908 Devices Inc. (MASS)
Revenue in 2023 (TTM): $50.23 M
According to 908 Devices Inc.'s latest financial reports the company's current revenue (TTM) is $50.23 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of 908 Devices Inc.
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $50.23 M | $23.37 M | $-40,018,000 | $-36,610,000 | $-36,399,000 |
| 2022 | $46.85 M | $26.02 M | $-35,382,000 | $-33,563,000 | $-31,744,000 |
| 2021 | $42.21 M | $23.23 M | $-21,683,000 | $-22,169,000 | $-22,116,000 |
| 2020 | $26.89 M | $14.92 M | $-11,843,000 | $-12,819,000 | $-6,936,000 |
| 2019 | $17.97 M | $8.14 M | $-10,943,000 | $-13,373,000 | $-15,204,000 |
| 2018 | $22.05 M | $12.39 M | $-5,493,000 | $-7,536,000 | $-7,536,000 |